Stay updated on Repotrectinib in Rearranged Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Repotrectinib in Rearranged Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Repotrectinib in Rearranged Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    - Updated the page to v3.2.0 and added a government-operational status notice clarifying potential delays and open status of NIH Clinical Center. - Removed the previous version tag v3.1.0.
    Difference
    7%
    Check dated 2025-10-05T17:27:05.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.2%
    Check dated 2025-09-28T10:43:23.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing the previous v3.0.1; the 'Back to Top' element was removed.
    Difference
    0.4%
    Check dated 2025-09-14T00:36:45.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.4%
    Check dated 2025-09-06T21:32:03.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has added a facility name and location details, while removing specific state, country, and city information. This indicates a shift towards a more generalized presentation of location data.
    Difference
    94%
    Check dated 2025-08-30T15:59:09.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T12:53:03.000Z thumbnail image

Stay in the know with updates to Repotrectinib in Rearranged Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Repotrectinib in Rearranged Solid Tumors Clinical Trial page.